📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of ZG-2305, an Orally Bioavailable Factor Inhibiting HIF Inhibitor for the Treatment of Obesity and Fatty Liver Disease. (2025)

First Author: Wu Y

Attributed to: Structural, Mechanistic and Functional Studies on Protein Hydroxylases funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.4c01698

PubMed Identifier: 39432709

Publication URI: http://europepmc.org/abstract/MED/39432709

Type: Journal Article/Review

Volume: 68

Parent Publication: Journal of medicinal chemistry

Issue: 1

ISSN: 0022-2623